CymaBay Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
CymaBay Therapeutics, Inc.‘s stocks are currently a part of 72 hedge funds’ portfolios, which represents 19.09% of the total amount of its stocks outstanding. This makes up a total of 16.76M shares of CymaBay Therapeutics, Inc.. Compared to the previous quarter, the number fell by -74.32% or -48.50M shares fewer. As for the holding position changes, 27.78% (20) of current hedge fund investors increased the number of shares held, 22.22% (16) of current holders sold a part of the shares held, and 12.5% (9) closed the holdings completely. 24 hedge funds are new holders of CymaBay Therapeutics, Inc. stock in Q1 2023, it is 33.33% of total holders.
Hedge funds holding CymaBay Therapeutics (Q2 2018 – Q1 2023)
| Q2 2018 | 116 |
|---|---|
| Q3 2018 | 131 |
| Q4 2018 | 129 |
| Q1 2019 | 142 |
| Q2 2019 | 131 |
| Q3 2019 | 133 |
| Q4 2019 | 110 |
| Q1 2020 | 99 |
| Q2 2020 | 112 |
| Q3 2020 | 118 |
| Q4 2020 | 142 |
| Q1 2021 | 129 |
| Q2 2021 | 110 |
| Q3 2021 | 111 |
| Q4 2021 | 111 |
| Q1 2022 | 109 |
| Q2 2022 | 101 |
| Q3 2022 | 96 |
| Q4 2022 | 118 |
| Q1 2023 | 72 |
Hedge funds changes in CymaBay Therapeutics positions (Q2 2018 – Q1 2023)
| Q2 2018 | 44 | 36 | 27 | 34 | -25 |
|---|---|---|---|---|---|
| Q3 2018 | 31 | 41 | 30 | 16 | 13 |
| Q4 2018 | 27 | 41 | 39 | 28 | -6 |
| Q1 2019 | 27 | 50 | 34 | 15 | 16 |
| Q2 2019 | 25 | 53 | 29 | 34 | -10 |
| Q3 2019 | 19 | 42 | 36 | 17 | 19 |
| Q4 2019 | 28 | 33 | 30 | 46 | -27 |
| Q1 2020 | 16 | 28 | 31 | 25 | -1 |
| Q2 2020 | 36 | 31 | 33 | 24 | -12 |
| Q3 2020 | 29 | 28 | 41 | 23 | -3 |
| Q4 2020 | 44 | 41 | 35 | 20 | 2 |
| Q1 2021 | 18 | 45 | 34 | 29 | 3 |
| Q2 2021 | 10 | 26 | 41 | 29 | 4 |
| Q3 2021 | 17 | 22 | 37 | 15 | 20 |
| Q4 2021 | 23 | 38 | 25 | 24 | 1 |
| Q1 2022 | 18 | 37 | 24 | 20 | 10 |
| Q2 2022 | 21 | 31 | 31 | 25 | -7 |
| Q3 2022 | 12 | 18 | 30 | 18 | 18 |
| Q4 2022 | 29 | 30 | 29 | 6 | 24 |
| Q1 2023 | 24 | 20 | 16 | 9 | 3 |
Hedge funds changes in CymaBay Therapeutics stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 640,000 | 491,000 |
|---|---|---|
| Q3 2018 | 766,000 | 669,000 |
| Q4 2018 | 250,000 | 454,000 |
| Q1 2019 | 1,618,000 | 852,000 |
| Q2 2019 | 7,812,000 | 1,279,000 |
| Q3 2019 | 5,580,000 | 44,000 |
| Q4 2019 | 930,000 | 55,000 |
| Q1 2020 | 955,000 | 0 |
| Q2 2020 | 2,072,000 | 1,688,000 |
| Q3 2020 | 3,640,000 | 951,000 |
| Q4 2020 | 1,898,000 | 3,978,000 |
| Q1 2021 | 1,322,000 | 3,454,000 |
| Q2 2021 | 2,095,000 | 3,448,000 |
| Q3 2021 | 1,413,000 | 2,722,000 |
| Q4 2021 | 1,379,000 | 1,986,000 |
| Q1 2022 | 805,000 | 456,000 |
| Q2 2022 | 801,000 | 345,000 |
| Q3 2022 | 865,000 | 520,000 |
| Q4 2022 | 2,788,183 | 1,495,718 |
| Q1 2023 | 2,099,935,000 | 1,520,243,000 |